IN BRIEF: Incoming Indivior CEO Ciaffoni, other directors buy shares
28th Feb 2025 14:06
Indivior PLC - Richmond, Virginia-based maker of medicines to treat substance use - Non-Executive Director Joe Ciaffoni buys 56,000 shares at USD8.96, worth USD501,519, on Thursday. Indivior on Thursday named Ciaffoni as its next chief executive officer, replacing Mark Crossley. The handover is expected to be after Indivior's annual general meeting in May. Indivior said Crossley is stepping down "by mutual agreement" and "following a distinguished tenure" as CEO since 2020. Crossley joined the board in December, and the 56,000 shares are his first holding. Most recently, he was CEO of Nasdaq-listed Collegium Pharmaceutical Inc. Read More